Clinical Trial Update: Abemaciclib in Patients with Oligodendroglioma [Phase 2]

View source ↗

Summary

Abemaciclib is being studied in a Phase 2 trial for adults with oligodendroglioma. The study is currently listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oligodendroglioma

Drugs mentioned

• Abemaciclib (abemaciclib)

Snippet

Sponsor: Stephen Bagley, MD, MSCE | Conditions: Oligodendroglioma, Adult | Phase 2 | Status: ACTIVE_NOT_RECRUITING